Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Induced conformational change in human IL-4 upon binding of a signal-neutralizing DARPin.
Proteins. 2015 Jun;83(6):1191-7. doi: 10.1002/prot.24815. Epub 2015 May 8.
Proteins. 2015.
PMID: 25900776
Free PMC article.
Selection of high-affinity Centyrin FN3 domains from a simple library diversified at a combination of strand and loop positions.
Diem MD, Hyun L, Yi F, Hippensteel R, Kuhar E, Lowenstein C, Swift EJ, O'Neil KT, Jacobs SA.
Diem MD, et al. Among authors: hippensteel r.
Protein Eng Des Sel. 2014 Oct;27(10):419-29. doi: 10.1093/protein/gzu016. Epub 2014 Apr 30.
Protein Eng Des Sel. 2014.
PMID: 24786107
Item in Clipboard
Interactions between chemokines: regulation of fractalkine/CX3CL1 homeostasis by SDF/CXCL12 in cortical neurons.
Cook A, Hippensteel R, Shimizu S, Nicolai J, Fatatis A, Meucci O.
Cook A, et al. Among authors: hippensteel r.
J Biol Chem. 2010 Apr 2;285(14):10563-71. doi: 10.1074/jbc.M109.035477. Epub 2010 Feb 2.
J Biol Chem. 2010.
PMID: 20124406
Free PMC article.
Item in Clipboard
Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Ross EA, Tian J, Abboud H, Hippensteel R, Melnick JZ, Pradhan RS, Williams LA, Hamm LL, Sprague SM.
Ross EA, et al. Among authors: hippensteel r.
Am J Nephrol. 2008;28(1):97-106. doi: 10.1159/000109398. Epub 2007 Oct 3.
Am J Nephrol. 2008.
PMID: 17914251
Clinical Trial.
Item in Clipboard
Role of the transcription factor E2F1 in CXCR4-mediated neurotoxicity and HIV neuropathology.
Shimizu S, Khan MZ, Hippensteel RL, Parkar A, Raghupathi R, Meucci O.
Shimizu S, et al. Among authors: hippensteel rl.
Neurobiol Dis. 2007 Jan;25(1):17-26. doi: 10.1016/j.nbd.2006.08.004. Epub 2006 Sep 28.
Neurobiol Dis. 2007.
PMID: 17011204
Free PMC article.
Item in Clipboard
A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4.
Abboud H, Coyne D, Smolenski O, Anger M, Lunde N, Qiu P, Hippensteel R, Pradhan RS, Palaparthy RV, Kavanaugh A, Melnick JZ, Williams LA, Batlle D.
Abboud H, et al. Among authors: hippensteel r.
Am J Nephrol. 2006;26(1):105-14. doi: 10.1159/000092033. Epub 2006 Mar 14.
Am J Nephrol. 2006.
PMID: 16543714
Clinical Trial.
Item in Clipboard
Antiproteinuric effect of oral paricalcitol in chronic kidney disease.
Agarwal R, Acharya M, Tian J, Hippensteel RL, Melnick JZ, Qiu P, Williams L, Batlle D.
Agarwal R, et al. Among authors: hippensteel rl.
Kidney Int. 2005 Dec;68(6):2823-8. doi: 10.1111/j.1523-1755.2005.00755.x.
Kidney Int. 2005.
PMID: 16316359
Free article.
Clinical Trial.
Item in Clipboard
Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment.
Drazen JM, Yandava CN, Dubé L, Szczerback N, Hippensteel R, Pillari A, Israel E, Schork N, Silverman ES, Katz DA, Drajesk J.
Drazen JM, et al. Among authors: hippensteel r.
Nat Genet. 1999 Jun;22(2):168-70. doi: 10.1038/9680.
Nat Genet. 1999.
PMID: 10369259
Clinical Trial.
Item in Clipboard
Cite
Cite